MK0826, ertapenem sodium

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Colorectal SurgeryInfectionsPelvic Infections

Phase 2

An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)

CompletedNCT00092170

Merck Sharp & Dohme LLCInfections, Pelvic Infections

Start: 2002-03-31End: 2004-01-31Target: 100Updated: 2017-02-17

Phase 3

A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)

CompletedNCT00090272

Merck Sharp & Dohme LLCColorectal Surgery

Start: 2002-04-30End: 2005-03-31Updated: 2017-02-17

Related Papers

Ertapenem versus cefotetan prophylaxis in elective colorectal surgery.

2006-12-01172 citations